TY - JOUR AU - Sebastian, S. AU - Settleman, J. AU - Reshkin, S. J. AU - Azzariti, A. AU - Bellizzi, A. AU - Paradiso, A. PY - 2006 DA - 2006// TI - The complexity of targeting EGFR signaling in cancer: from expression to turnover JO - Biochim Biophys Acta VL - 1766 ID - Sebastian2006 ER - TY - STD TI - Congdon KL, Gedeon PC, Suryadevara CM, Caruso HG, Cooper LJ, Heimberger AB, Sampson JH. Epidermal growth factor receptor and variant III targeted immunotherapy. Neuro Oncol. 2014;16 Suppl 8:viii20–25. ID - ref2 ER - TY - JOUR AU - Cohen, A. L. AU - Colman, H. PY - 2015 DA - 2015// TI - Glioma biology and molecular markers JO - Cancer Treat Res VL - 163 UR - https://doi.org/10.1007/978-3-319-12048-5_2 DO - 10.1007/978-3-319-12048-5_2 ID - Cohen2015 ER - TY - JOUR AU - Saito, T. AU - Mitomi, H. AU - Yao, T. PY - 2015 DA - 2015// TI - Molecular pathology and potential therapeutic targets in esophageal basaloid squamous cell carcinoma JO - Int J Clin Exp Pathol VL - 8 ID - Saito2015 ER - TY - JOUR AU - Bejar, C. AU - Maubec, E. PY - 2014 DA - 2014// TI - Therapy of advanced squamous cell carcinoma of the skin JO - Curr Treat Options Oncol VL - 15 UR - https://doi.org/10.1007/s11864-014-0280-x DO - 10.1007/s11864-014-0280-x ID - Bejar2014 ER - TY - JOUR AU - Zhang, L. AU - Fang, C. AU - Xu, X. AU - Li, A. AU - Cai, Q. AU - Long, X. PY - 2015 DA - 2015// TI - Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis JO - Biomed Res Int VL - 2015 ID - Zhang2015 ER - TY - JOUR AU - Matikas, A. AU - Mistriotis, D. AU - Georgoulias, V. AU - Kotsakis, A. PY - 2015 DA - 2015// TI - Current and future approaches in the management of non-small-cell lung cancer patients with resistance to EGFR TKIs JO - Clin Lung Cancer VL - 16 UR - https://doi.org/10.1016/j.cllc.2014.12.013 DO - 10.1016/j.cllc.2014.12.013 ID - Matikas2015 ER - TY - JOUR AU - Ribeiro, F. A. AU - Noguti, J. AU - Oshima, C. T. AU - Ribeiro, D. A. PY - 2014 DA - 2014// TI - Effective targeting of the epidermal growth factor receptor (EGFR) for treating oral cancer: a promising approach JO - Anticancer Res VL - 34 ID - Ribeiro2014 ER - TY - STD TI - Choi BD, Kuan CT, Cai M, Archer GE, Mitchell DA, Gedeon PC, Sanchez-Perez L, Pastan I, Bigner DD, Sampson JH. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc Natl Acad Sci U S A. 2013;110(1):270–5. ID - ref9 ER - TY - JOUR AU - Yamazaki, H. AU - Ohba, Y. AU - Tamaoki, N. AU - Shibuya, M. PY - 1990 DA - 1990// TI - A deletion mutation within the ligand-binding domain is responsible for activation of epidermal growth-factor receptor gene in human brain-tumors JO - Jpn J Cancer Res VL - 81 UR - https://doi.org/10.1111/j.1349-7006.1990.tb02644.x DO - 10.1111/j.1349-7006.1990.tb02644.x ID - Yamazaki1990 ER - TY - JOUR AU - Sugawa, N. AU - Ekstrand, A. J. AU - James, C. D. AU - Collins, V. P. PY - 1990 DA - 1990// TI - Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas JO - Proc Natl Acad Sci U S A VL - 7 UR - https://doi.org/10.1073/pnas.87.21.8602 DO - 10.1073/pnas.87.21.8602 ID - Sugawa1990 ER - TY - STD TI - Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A. 1992;89(7):2965–9. ID - ref12 ER - TY - STD TI - Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M. Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol. 1988;8(4):1816–20. ID - ref13 ER - TY - JOUR AU - Pedersen, M. W. AU - Meltorn, M. AU - Damstrup, L. AU - Poulsen, H. PY - 2001 DA - 2001// TI - The type III epidermal growth factor receptor mutation. In: biological significance and potential target for anti-cancer therapy JO - Ann Oncol VL - 12 UR - https://doi.org/10.1023/A:1011177318162 DO - 10.1023/A:1011177318162 ID - Pedersen2001 ER - TY - JOUR AU - Gan, H. K. AU - Cvrljevic, A. N. AU - Johns, T. G. PY - 2013 DA - 2013// TI - The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered JO - FEBS J VL - 280 UR - https://doi.org/10.1111/febs.12393 DO - 10.1111/febs.12393 ID - Gan2013 ER - TY - JOUR AU - Kuan, C. T. AU - Wikstrand, C. J. AU - Bigner, D. D. PY - 2001 DA - 2001// TI - EGF mutant receptor vIII as a molecular target in cancer therapy JO - Endocr Relat Cancer VL - 8 UR - https://doi.org/10.1677/erc.0.0080083 DO - 10.1677/erc.0.0080083 ID - Kuan2001 ER - TY - JOUR AU - Wang, L. H. PY - 2004 DA - 2004// TI - Molecular signaling regulating anchorage-independent growth of cancer cells JO - Mt Sinai J Med VL - 71 ID - Wang2004 ER - TY - JOUR AU - Chiarugi, P. AU - Giannoni, E. PY - 2008 DA - 2008// TI - Anoikis: a necessary death program for anchorage-dependent cells JO - Biochem Pharmacol VL - 76 UR - https://doi.org/10.1016/j.bcp.2008.07.023 DO - 10.1016/j.bcp.2008.07.023 ID - Chiarugi2008 ER - TY - JOUR AU - Sakamoto, S. AU - Kyprianou, N. PY - 2010 DA - 2010// TI - Targeting anoikis resistance in prostate cancer metastasis JO - Mol Aspects Med VL - 31 UR - https://doi.org/10.1016/j.mam.2010.02.001 DO - 10.1016/j.mam.2010.02.001 ID - Sakamoto2010 ER - TY - JOUR AU - Paoli, P. AU - Giannoni, E. AU - Chiarugi, P. PY - 2013 DA - 2013// TI - Anoikis molecular pathways and its role in cancer progression JO - Biochim Biophys Acta VL - 1833 UR - https://doi.org/10.1016/j.bbamcr.2013.06.026 DO - 10.1016/j.bbamcr.2013.06.026 ID - Paoli2013 ER - TY - JOUR AU - Guadamillas, M. C. AU - Cerezo, A. AU - Pozo, M. A. PY - 2011 DA - 2011// TI - Overcoming anoikis—pathways to anchorage-independent growth in cancer JO - J Cell Sci VL - 24 UR - https://doi.org/10.1242/jcs.072165 DO - 10.1242/jcs.072165 ID - Guadamillas2011 ER - TY - STD TI - Foley JM, Scholten DJ, Monks NR, Cherba D, Monsma DJ, Davidson P, Dylewski D, Dykema K, Winn ME, Steensma MR. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling. J Transl Med. 2015;13:110. ID - ref22 ER - TY - JOUR AU - Seetharam, L. AU - Gotoh, N. AU - Maru, Y. AU - Neufeld, G. AU - Yamaguchi, S. AU - Shibuya, M. PY - 1995 DA - 1995// TI - A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF JO - Oncogene VL - 10 ID - Seetharam1995 ER - TY - STD TI - Bax DA, Gaspar N, Little SE, Marshall L, Perryman L, Regairaz M, Viana-Pereira M, Vuononvirta R, Sharp SY, Reis-Filho JS et al. EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin Cancer Res. 2009;15(18):5753–61. ID - ref24 ER - TY - JOUR AU - Liccardi, G. AU - Hartley, J. A. AU - Hochhauser, D. PY - 2011 DA - 2011// TI - EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2384 DO - 10.1158/0008-5472.CAN-10-2384 ID - Liccardi2011 ER - TY - JOUR AU - Günther, W. AU - Pawlak, E. AU - Damasceno, R. AU - Arnold, H. AU - Terzis, A. J. PY - 2003 DA - 2003// TI - Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids JO - Br J Cancer VL - 88 UR - https://doi.org/10.1038/sj.bjc.6600711 DO - 10.1038/sj.bjc.6600711 ID - Günther2003 ER - TY - JOUR AU - Weiswald, L. B. AU - Guinebretière, J. M. AU - Richon, S. AU - Bellet, D. AU - Saubaméa, B. AU - Dangles-Marie, V. PY - 2010 DA - 2010// TI - In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-106 DO - 10.1186/1471-2407-10-106 ID - Weiswald2010 ER - TY - JOUR AU - Bolstad, B. M. AU - Irizarry, R. A. AU - Astrand, M. AU - Speed, T. P. PY - 2003 DA - 2003// TI - A comparison of normalization methods for high density oligonucleotide array data based on variance and bias JO - Bioinformatics VL - 19 UR - https://doi.org/10.1093/bioinformatics/19.2.185 DO - 10.1093/bioinformatics/19.2.185 ID - Bolstad2003 ER - TY - STD TI - Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5(10):R80. ID - ref29 ER - TY - JOUR AU - Quackenbush, J. PY - 2002 DA - 2002// TI - Microarray data normalization and transformation JO - Nat Genet VL - 32 UR - https://doi.org/10.1038/ng1032 DO - 10.1038/ng1032 ID - Quackenbush2002 ER - TY - STD TI - Wenzel C, Riefke B, Gründemann S, Krebs A, Christian S, Prinz F, Osterland M, Golfier S, Räse S, Ansari N et al. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions. Exp Cell Res. 2014;323(1):131–43. ID - ref31 ER - TY - STD TI - Goswami A, Burikhanov R, de Thonel A, Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T, Rangnekar VM et al. Binding and phosphorylation of par-4 by akt is essential for cancer cell survival. Mol Cell. 2005;20(1):33–44. ID - ref32 ER - TY - JOUR AU - Gauvin, T. J. AU - Fukui, J. AU - Peterson, J. R. AU - Higgs, H. N. PY - 2009 DA - 2009// TI - Isoform-selective chemical inhibition of mDia-mediated actin assembly JO - Biochemistry VL - 48 UR - https://doi.org/10.1021/bi901354z DO - 10.1021/bi901354z ID - Gauvin2009 ER - TY - JOUR AU - Moscatello, D. K. AU - Holgado-Madruga, M. AU - Emlet, D. R. AU - Montgomery, R. B. AU - Wong, A. J. PY - 1998 DA - 1998// TI - Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.1.200 DO - 10.1074/jbc.273.1.200 ID - Moscatello1998 ER - TY - JOUR AU - Alwan, H. A. AU - Zoelen, E. J. AU - Leeuwen, J. E. PY - 2003 DA - 2003// TI - Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination JO - J Biol Chem VL - 278 UR - https://doi.org/10.1074/jbc.M301326200 DO - 10.1074/jbc.M301326200 ID - Alwan2003 ER - TY - JOUR AU - Davies, G. C. AU - Ryan, P. E. AU - Rahman, L. AU - Zajac-Kaye, M. AU - Lipkowitz, S. PY - 2006 DA - 2006// TI - EGFRvIII undergoes activation-dependent downregulation mediated by the Cbl proteins JO - Oncogene VL - 25 UR - https://doi.org/10.1038/sj.onc.1209662 DO - 10.1038/sj.onc.1209662 ID - Davies2006 ER - TY - STD TI - Badaboina S, Bai HW, Na YH, Park CH, Kim TH, Lee TH, Chung BY. Novel radiolytic rotenone derivative, rotenoisin B with potent anti-carcinogenic activity in hepatic cancer cells. Int J Mol Sci. 2015;16(8):16806–15. ID - ref37 ER - TY - JOUR AU - Hirschhaeuser, F. AU - Sattler, U. G. AU - Mueller-Klieser, W. PY - 2011 DA - 2011// TI - Lactate: a metabolic key player in cancer JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-11-1457 DO - 10.1158/0008-5472.CAN-11-1457 ID - Hirschhaeuser2011 ER -